Mayo Clinic

Running trials

• Not yet recruiting

  The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

  NCT05499702· Phase 2· Source

• Recruiting

  Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube

  NCT07556484· Phase 1· Source

• Not yet recruiting

  Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration

  NCT07221656· Source

• Not yet recruiting

  A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)

  NCT05793567· Source

• Not yet recruiting

  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  NCT07281027· Phase 3· Source

• Not yet recruiting

  Surgical Window Study of CM93 in Subjects With Recurrent Glioblastoma (rGBM)

  NCT07927491· Phase 1· Source

• Not yet recruiting

  Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial

  NCT06170281· Source

• Not yet recruiting

  Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

  NCT07206589· Source

• Not yet recruiting

  HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

  NCT07612007· Phase 2· Source

• Not yet recruiting

  Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas

  NCT07620548· Phase 2· Source

• Not yet recruiting

  RESTORE: Restoring State-dependent Thalamocortical Oscillations in Epilepsy

  NCT07927985· Source

• Not yet recruiting

  A Study Of Remote Patient Monitoring (RPM) Program For Cancer Patients Initiating Cancer-directed Therapy

  NCT07810400· Source

• Not yet recruiting

  A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment

  NCT07926321· Phase 2· Source

• Recruiting

  Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial

  NCT07783581· Phase 2· Source

• Recruiting

  EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression

  NCT07862205· Source

• Not yet recruiting

  Peri-procedural Weighted Blanket Use for ECT

  NCT07900646· Source

• Not yet recruiting

  Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus

  NCT07843420· Phase 2· Source

• Not yet recruiting

  Induction Chemoimmunotherapy to Prevent Laryngectomy in Advanced Laryngeal Cancer and Hypopharyngeal Cancer

  NCT07923877· Phase 2· Source

• Recruiting

  Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction

  NCT07401771· Source

• Not yet recruiting

  Acute Stimulation and Modulation of Stereotyped High-Frequency Oscillations

  NCT06898138· Source

• Not yet recruiting

  Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

  NCT07795593· Phase 4· Source

• Recruiting

  A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.

  NCT07357675· Phase 3· Source

• Not yet recruiting

  Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric Physiology in Adults With Obesity

  NCT07893457· Phase 4· Source

• Not yet recruiting

  Cascade Testing In Identifying At-risk Family Members Of Individuals With Familial Hypercholesterolemia (FH) In PCP

  NCT07653555· Source

• Recruiting

  A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

  NCT07830732· Phase 3· Source

• Not yet recruiting

  A Study for Cerebral Open Flow Microperfusion

  NCT07089758· Source

• Not yet recruiting

  Rimegepant For Endometriosis Pain

  NCT07795125· Phase 2· Source

• Recruiting

  A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

  NCT07768189· Phase 3· Source

• Not yet recruiting

  Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

  NCT07520110· Phase 3· Source

• Recruiting

  Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  NCT07817875· Phase 3· Source

• Recruiting

  Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

  NCT07700979· Phase 3· Source

• Recruiting

  Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors

  NCT07856394· Source

• Not yet recruiting

  Senyo Health App - Comorbid Alcohol Use Disorder Treatment in Individuals With Bipolar Disorder Using a Telehealth Collaborative Care Platform

  NCT07556861· Source

• Not yet recruiting

  A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery

  NCT07570940· Phase 4· Source

• Recruiting

  A Phase 1 Dose-escalation and Expansion Study of In Vivo BCMA-CAR T Cell Therapy (VV169) in Patients With Relapsed or Refractory Multiple Myeloma

  NCT07802717· Phase 1· Source

• Not yet recruiting

  MCG In Long QT Syndrome

  NCT07270211· Source

• Not yet recruiting

  Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes

  NCT07808385· Source

• Recruiting

  Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma

  NCT07805954· Phase 3· Source

• Recruiting

  Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma

  NCT07708961· Phase 2· Source

• Recruiting

  A Study Of Acute Decompensated Heart Failure

  NCT07572955· Source

• Recruiting

  SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

  NCT07850284· Source

• Recruiting

  Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy

  NCT07662824· Source

• Recruiting

  A Community Based Intervention to Improve Cervical Cancer Screening Among Women in the Hispanic and East African Immigrant Community

  NCT07890402· Source

• Enrolling by invitation

  Patient Reported Outcomes Following Percutaneous Lung Ablation

  NCT07720102· Source

• Recruiting

  Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

  NCT07650240· Phase 2· Source

• Recruiting

  GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

  NCT07301268· Phase 2· Source

• Not yet recruiting

  Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

  NCT07524634· Phase 2· Source

• Recruiting

  Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF Agents

  NCT07567833· Phase 4· Source

• Recruiting

  HCMR Re-Imaging Study

  NCT07054073· Source

• Not yet recruiting

  Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

  NCT07243067· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers61 recruiting
• Lung cancer52 recruiting
• Colorectal cancer41 recruiting
• Ovarian cancer36 recruiting
• Heart failure34 recruiting
• Prostate cancer34 recruiting
• Pancreatic cancer33 recruiting
• Multiple myeloma27 recruiting
• Bladder cancer25 recruiting
• Gastric and esophageal cancer24 recruiting
• Sarcoma24 recruiting
• Endometrial cancer23 recruiting
• Liver and biliary tract cancer23 recruiting
• Chronic lymphocytic leukaemia22 recruiting
• Head and neck cancer20 recruiting
• High blood pressure20 recruiting
• Epilepsy19 recruiting
• Obesity18 recruiting
• Coronary artery disease16 recruiting
• Kidney cancer16 recruiting
• Melanoma16 recruiting
• Glioblastoma15 recruiting
• Neuroendocrine tumours15 recruiting
• Triple-negative breast cancer14 recruiting
• Acute myeloid leukemia13 recruiting
• Amyloidosis13 recruiting
• Metastatic breast cancer13 recruiting
• Crohn's disease11 recruiting
• Diffuse large B-cell lymphoma11 recruiting
• Mesothelioma11 recruiting
• Stroke11 recruiting
• Acute lymphoblastic leukaemia10 recruiting
• Alzheimer disease10 recruiting
• Cervical cancer10 recruiting
• Mantle cell lymphoma10 recruiting
• Myelodysplastic syndromes10 recruiting
• Chronic kidney disease9 recruiting
• Chronic myeloid leukaemia9 recruiting
• Follicular lymphoma9 recruiting
• Lewy body dementia9 recruiting
• Type 2 diabetes9 recruiting
• ALS (motor neurone disease)8 recruiting
• Atrial fibrillation8 recruiting
• Ulcerative colitis8 recruiting
• Parkinson disease7 recruiting
• Pulmonary arterial hypertension7 recruiting
• Depression6 recruiting
• Fatty liver disease (MASLD/MASH)6 recruiting
• Idiopathic pulmonary fibrosis6 recruiting
• Myeloproliferative neoplasms6 recruiting
• Polycystic kidney disease6 recruiting
• Rheumatoid arthritis6 recruiting
• Type 1 diabetes6 recruiting
• Bipolar disorder5 recruiting
• Frontotemporal dementia5 recruiting
• Lupus (SLE)5 recruiting
• Migraine5 recruiting
• Long COVID and ME/CFS4 recruiting
• Multiple sclerosis4 recruiting
• Primary biliary cholangitis4 recruiting
• Systemic sclerosis (scleroderma)4 recruiting
• ANCA-associated vasculitis3 recruiting
• Asthma3 recruiting
• COPD3 recruiting
• Endometriosis3 recruiting
• Hodgkin lymphoma3 recruiting
• Hypertrophic cardiomyopathy3 recruiting
• Neuroblastoma3 recruiting
• Diabetic eye disease2 recruiting
• Macular degeneration2 recruiting
• Myasthenia gravis2 recruiting
• Retinitis pigmentosa2 recruiting
• Thyroid cancer2 recruiting
• Ankylosing spondylitis1 recruiting
• Atopic dermatitis (eczema)1 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Cystic fibrosis1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Friedreich ataxia1 recruiting
• Glaucoma1 recruiting
• Haemophilia1 recruiting
• Hepatitis B1 recruiting
• HIV1 recruiting
• IgA nephropathy1 recruiting
• Osteoporosis1 recruiting
• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting
• Sickle cell disease1 recruiting
• Sjögren's disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  Glucose and Blood Pressure During Pregnancy

  NCT04979312· Source

• Withdrawn

  Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus

  NCT05985135· Source

• Withdrawn

  A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

  NCT07428044· Phase 2· Source

• Recruiting

  Renal Pelvic Denervation Pilot Trial

  NCT07005050· Source

• Completed

  Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)

  NCT07240831· Source

• Withdrawn

  Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung

  NCT05717140· Phase 1· Source

• Completed

  NAL ER IPF Respiratory Function and Safety Study

  NCT07036029· Phase 1· Source

• Terminated

  Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma

  NCT07045727· Source

• Recruiting

  Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

  NCT05730283· Phase 2· Source

• Terminated

  Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

  NCT06790966· Phase 3· Source

• Completed

  NE3107 in Adults With Neurological Symptoms of Long COVID

  NCT06847191· Phase 2· Source

• Completed

  Innovative Automated Insulin Delivery System for Type 2 Diabetes

  NCT06853990· Source

• Completed

  Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

  NCT06870539· Source

• Completed

  REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

  NCT06788535· Phase 3· Source

• Completed

  Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree

  NCT06851546· Source

• Terminated

  Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery

  NCT06280092· Early phase 1· Source

• Completed

  Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

  NCT06604442· Phase 4· Source

• Completed

  A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:

  NCT06676072· Source

• Completed

  InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors

  NCT06703996· Source

• Completed

  Open-Label Extension Study of Setmelanotide

  NCT06596135· Phase 3· Source

• Completed

  Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

  NCT06377930· Phase 2· Source

• Completed

  Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

  NCT06625047· Phase 4· Source

• Terminated

  Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)

  NCT05554354· Phase 2· Source

• Withdrawn

  A Study of a Lifestyle Program on Recurrent Atrial Fibrillation

  NCT06155357· Source

• Withdrawn

  Defining Musical Toxicity and Its Effect on Patient Well-being

  NCT06494046· Source

• Withdrawn

  Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors

  NCT05653661· Phase 1· Source

• Completed

  RECOVER-ENERGIZE Platform Protocol

  NCT06404047· Source

• Completed

  Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension

  NCT06409026· Phase 4· Source

• Completed

  Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis

  NCT06316999· Source

• Completed

  MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

  NCT06212466· Source

• Terminated

  NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma

  NCT06420349· Phase 1· Source

• Recruiting

  Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)

  NCT03138863· Source

• Completed

  Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

  NCT06331624· Phase 2· Source

• Completed

  Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision

  NCT05879302· Source

• Completed

  Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas

  NCT06213571· Source

• Completed

  RECOVER-AUTONOMIC Platform Protocol

  NCT06305780· Phase 2· Source

• Completed

  Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

  NCT05730712· Phase 2· Source

• Completed

  Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

  NCT06273124· Source

• Terminated

  CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations

  NCT05689021· Phase 2· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

  NCT06196879· Phase 2· Source

• Completed

  Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity

  NCT05343000· Source

• Terminated

  Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen

  NCT05443971· Phase 1· Source

• Completed

  "Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

  NCT05410509· Source

• Completed

  A Study of Pulmonary Hypertension Peripheral Limitations

  NCT05968859· Source

• Completed

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· Phase 3· Source

• Recruiting

  BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  NCT06059638· Source

• Completed

  Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT06058793· Phase 3· Source

• Completed

  Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution

  NCT05938699· Phase 2/3· Source

• Completed

  Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

  NCT06234488· Source

• Completed

  A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted EHR Dashboard and Mobile Device Compared With Usual Asthma Care to Treat 6-17 Year Old Patients

  NCT06062433· Source

Trial sites

• Mayo Clinic1 trial
• Mayo Clinic135 trials
• Mayo Clinic1 trial
• Mayo Clinic1 trial
• Mayo Clinic59 trials
• #1016, Mayo Clinic1 trial
• Mayo Clinic597 trials
• Mayo Clinic, 1216 Second Street SW1 trial
• Mayo Clinic, 200 First Street SW1 trial
• Mayo Clinic - Appendix A & B1 trial
• Mayo Clinic - Cancer Center - Rochester - PPDS1 trial
• Mayo Clinic, Cardiovascular Research1 trial
• Mayo Clinic - Children's Center - Rochester3 trials
• Mayo Clinic, Clinical Trials Referral Office1 trial
• Mayo Clinic (Data Collection and Data Analysis)1 trial
• Mayo Clinic (Data Collection Only)4 trials
• Mayo Clinic, Department of Ophthalmology1 trial
• Mayo Clinic Division of Nursing1 trial
• Mayo Clinic, Division of Pulmonary and Critical Care Medicine1 trial
• Mayo Clinic in Rochester638 trials
• Mayo Clinic in Rochester, Minnesota14 trials
• Mayo Clinic in Rochester, Minnesota (Site 0091)1 trial
• Mayo Clinic in Rochester, Minnesota (Site 0131)1 trial
• Mayo Clinic in Rochester, Minnesota (Site 0147)1 trial
• Mayo Clinic in Rochester, Minnesota (Site 5024)1 trial
• Mayo Clinic in Rochester - Minnesota- Site Number : 84000041 trial
• Mayo Clinic in Rochester - Minnesota- Site Number : 84000051 trial
• Mayo Clinic in Rochester - Minnesota- Site Number : 84000081 trial
• Mayo Clinic in Rochester - Minnesota- Site Number : 84000191 trial
• Mayo Clinic in Rochester - Minnesota- Site Number : 84000571 trial
• Mayo Clinic Mayo Rochester1 trial
• Mayo Clinic, Merz Investigational Site #00102122 trials
• Mayo Clinic - Minnesota /ID# 2560511 trial
• Mayo Clinic - Minnesota /ID# 2639771 trial
• Mayo Clinic (MN)1 trial
• Mayo Clinic of Rochester Site Number : 84000031 trial
• Mayo Clinic - Oncology1 trial
• Mayo Clinic, Patient Location1 trial
• Mayo Clinic - PIN6 trials
• Mayo Clinic - PPDS3 trials
• Mayo Clinic - PPDS- Site Number : 84000351 trial
• Mayo Clinic - Rochester232 trials
• Mayo Clinic - Rochester, Department of Oncology1 trial
• Mayo Clinic - Rochester /ID# 1168991 trial
• Mayo Clinic - Rochester /ID# 1473041 trial
• Mayo Clinic - Rochester /ID# 1492451 trial
• Mayo Clinic - Rochester /ID# 1498941 trial
• Mayo Clinic - Rochester /ID# 1516811 trial
• Mayo Clinic - Rochester /ID# 1630861 trial
• Mayo Clinic - Rochester /ID# 1646911 trial
• Mayo Clinic - Rochester /ID# 2004551 trial
• Mayo Clinic - Rochester /ID# 2010911 trial
• Mayo Clinic - Rochester /ID# 2156031 trial
• Mayo Clinic - Rochester /ID# 2235061 trial
• Mayo Clinic - Rochester /ID# 2386831 trial
• Mayo Clinic - Rochester /ID# 2428441 trial
• Mayo Clinic - Rochester /ID# 2462281 trial
• Mayo Clinic - Rochester /ID# 2511641 trial
• Mayo Clinic - Rochester /ID# 2552581 trial
• Mayo Clinic - Rochester /ID# 2565941 trial
• Mayo Clinic - Rochester /ID# 2573011 trial
• Mayo Clinic - Rochester /ID# 2582951 trial
• Mayo Clinic - Rochester /ID# 2584021 trial
• Mayo Clinic - Rochester /ID# 2628071 trial
• Mayo Clinic-Rochester /ID# 2655501 trial
• Mayo Clinic-Rochester /ID# 2735081 trial
• Mayo Clinic-Rochester /ID# 2736061 trial
• Mayo Clinic-Rochester /ID# 2745121 trial
• Mayo Clinic - Rochester Minnesota3 trials
• Mayo Clinic, Rochester, MN6 trials
• Mayo Clinic - Rochester - Neurology1 trial
• Mayo Clinic - Rochester (Site 0073)1 trial
• Mayo Clinic - Rochester (Site 0138)1 trial
• Mayo Clinic - Rochester (Site 0148)1 trial
• Mayo Clinic - Rochester (Site 2706)1 trial
• Mayo Clinic - Rochester - Site #3321 trial
• Mayo Clinic (Site 0026)1 trial
• Mayo Clinic- Site Number : 141 trial
• Mayo Clinic- Site Number : 84000101 trial
• Mayo Clinic- Site Number : 84001113 trials
• Mayo Clinic, St. Mary's Campus1 trial
• Mayo Clinic - Transplant Center - Rochester1 trial
• The Mayo Clinic4 trials
• Mayo Clinic42 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure630 works · 65 trials
• Stroke558 works · 22 trials
• Alzheimer disease448 works · 19 trials
• Obesity418 works · 44 trials
• Atrial fibrillation357 works · 26 trials
• Liver and biliary tract cancer224 works · 65 trials
• Lung cancer223 works · 143 trials
• Prostate cancer217 works · 74 trials
• Multiple myeloma206 works · 89 trials
• Epilepsy184 works · 46 trials
• Colorectal cancer179 works · 77 trials
• Melanoma170 works · 54 trials
• Chronic kidney disease167 works · 18 trials
• Type 2 diabetes165 works · 21 trials
• Coronary artery disease140 works · 27 trials
• Amyloidosis137 works · 26 trials
• Parkinson disease119 works · 15 trials
• Pancreatic cancer118 works · 65 trials
• Glioblastoma118 works · 41 trials
• Sarcoma116 works · 68 trials
• Multiple sclerosis99 works · 11 trials
• Asthma97 works · 11 trials
• Ovarian cancer97 works · 72 trials
• Hypertrophic cardiomyopathy91 works · 12 trials
• Hodgkin lymphoma87 works · 15 trials
• Bladder cancer86 works · 45 trials
• Migraine81 works · 8 trials
• Neuroendocrine tumours81 works · 31 trials
• Bipolar disorder80 works · 8 trials
• Crohn's disease79 works · 26 trials